Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Redwood City, USA
575 Chesapeake Drive
Redwood City, CA, 94063
USA

People

CFO
President and CEO
Board of Directors
Board of Directors

Funding

TOTAL $24.8M
FUNDING TOTAL $24.8M
Venture Round, 11/2009
$14.8M
Private Equity, 6/2012
$10M
DEBT TOTAL $68.8M
Debt, 9/2010
$8M
Debt, 7/2011
$20.8M
Debt, 12/2013
Hercules Technology Growth Capital
$40M

Tags

AcelRx Pharmaceuticals

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of pain and other conditions. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute post-operative pain in the hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures. It serves patients, physicians, regulators, and payers. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is based in Redwood City, California.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. AcelRx Gets $40M In Credit Facility (silicontap.com) [edit]
  6. AcelRx falls short in $40M IPO (fiercebiotech.com) [edit]
    AcelRx gets $20M loan for Phase III work (fiercebiotech.com) [edit]
Edit This Page
Last Edited 3/10/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy